Dr. David M. Bear, DO

Dr. Bear practices at Emerald Coast Center For Neurological Disorders in Pensacola, Florida.

Dr. Bear's NPI, 1689643645, was assigned on March 14, 2006. Dr. Bear holds Florida license OS 9669.

Dr. Bear's primary practice is Emerald Coast Center for Neurological Disorders, at 1110 Airport Blvd Suite B Suite B, Pensacola, FL 32504-8608. The practice phone is (850) 438-1136.

Dr. Bear's primary practice is Emerald Coast Center For Neurological Disorders in Pensacola, Florida. Dr. Bear is also affiliated with Ascension Sacred Heart Pensacola. The medical group on file is Emerald Coast Neurology. Dmand AI also links Dr. Bear to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bear practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bear's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bear is licensed in Florida.

CMS data shows 93,921 Medicare services from Dr. Bear across 48 procedure codes in 2024, for 1,569 Medicare patients. Medicare paid $950,144 for them. Every service was in an office.

CMS counts 1,569 Medicare patients who saw Dr. Bear in 2024. The largest group is 65 to 74, with 648 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bear's median patient age at 66, with 65% women.

In 2024, Dr. Bear wrote 7,201 Medicare Part D claims for 793 patients. 79% of them were for generic drugs. CMS names the drug for 6,798 of them, across 117 drugs with 11 or more claims each, at $3,698,793 in total drug cost. In 2023, CMS named 6,019 claims across 102 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bear for performance year 2024, reported individually. Dr. Bear accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 64 procedures of skin biopsy by Dr. Bear, more than 71% of the clinicians it reports for that procedure.

Dmand AI links Dr. Bear to 10 clinical trials, 2 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Alzheimer Disease, Migraine Disorders and Headache Disorders, Primary. Eli Lilly and Company sponsors the most, 8. Open Payments lists research payments to Dr. Bear that name 9 trials.

CMS Open Payments shows 2,797 general payments to Dr. Bear from 91 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Eli Lilly and Company paid the most, $262,675. It also lists 32 research payments totaling $181,341 from 2020 to 2025, naming 9 clinical trials.